Skip to main content
. 2022 Jul;23(7):2325–2332. doi: 10.31557/APJCP.2022.23.7.2325

Table 3.

Association of the FIT-negative and TCS-only Groups for AN and SSL with Clinical Features

FIT-negative (n=63) TCS-only (n=55) P-value FIT-negative (n=159) TCS-only P-value
Sex, n (%) Male 47 (74.6) 37 (67.3) 0.42 87 (54.7) 72 (52.9) 0.82
Female 16 (25.4) 18 (32.7) 72 (45.3) 64 (47.1)
Age group, years, n (%) 49–54 24 (38.1) 21 (38.2) 0.99 75 (47.2) 78 (57.4) 0.1
55–60 39 (61.9) 34 (61.8) 84 (52.8) 58 (42.6)
Smoking, n (%) Never 21 (33.3) 22 (40.0) 0.57 69 (43.4) 60 (44.1) 0.91
Current or past 42 (66.7) 33 (60.0) 90 (56.6) 76 (55.9)
Alcohol, n (%) Non-drinker 57 (90.5) 48 (87.3) 0.77 137 (86.2) 118 (86.8) 0.99
Drinker 6 (9.5) 7 (12.7) 22 (13.8) 18 (13.2)
BMI, kg/m2, median (IQR) 24.0 (22.4–26.4) 24.3 (22.4–25.4) 0.57 24.1 (21.1–26.7) 23.3 (21.3–26.1) 0.36
Family history of CRC, n (%) Yes 8 (12.7) 16 (29.1) 0.04 20 (12.6) 21 (15.4) 0.5
No 55 (87.3) 39 (70.9) 139 (87.4) 115 (84.6)
Location of the polyps, n (%) Right 31 (49.2) 15 (27.3) 0.02 114 (71.7) 101 (74.3) 0.2
Left 26 (41.3) 37 (67.3) 35 (22.0) 21 (15.4)
Bilateral 6 (9.5) 3 (5.5) 10 (6.3) 14 (10.3)

BMI, body mass index; IQR, interquartile range; CRC, colorectal cancer; AN, advanced neoplasm; SSL, sessile serrated lesion; FIT,fecal immunochemical test; TCS, total colonoscopy